Clinical Biomarkers

Companion diagnostics (CDx) services

Advancing Precision Medicine with OHMX.bio

Companion diagnostics (CDx) play a crucial role in precision medicine, ensuring that the right treatment reaches the right patient. OHMX.bio offers a comprehensive suite of services to support the discovery, evaluation, and optimization of CDx solutions. With deep expertise in both laboratory sciences and bioinformatics, OHMX.bio delivers robust and clinically relevant biomarker assays that bridge the gap between drug development and patient care.

CDx development: From discovery to implementation

The development of companion diagnostics requires a multi-phase approach, from early biomarker discovery to full clinical validation. OHMX.bio integrates cutting-edge sequencing, proteomics, and molecular biology techniques to guide CDx programs at every stage.

Biomarker Discovery & Validation

Using high-throughput sequencing (NGS), mass spectrometry, and qPCR-based assays, OHMX.bio identifies and validates predictive biomarkers that correlate with drug efficacy and patient response.

Analytical & Clinical Performance Optimization

OHMX.bio ensures the highest assay sensitivity, specificity, and reproducibility, optimizing analytical parameters for regulatory approval.

OHMX.bio - Innovative omics solutions
OHMX.bio_Innovative omics solutions_Scientific Excellence

Key technologies supporting CDx

Next-Generation Sequencing (NGS)

Comprehensive genomic profiling for predictive and prognostic biomarker identification.

Mass Spectrometry-Based Proteomics

High-precision protein biomarker quantification for drug-response analysis.

qPCR

Sensitive and rapid detection of actionable genetic variants.

Flow Cytometry & ELISA

Functional validation of biomarkers in patient-derived samples.

Integrated bioinformatics for CDx optimization

Bioinformatics plays a vital role in companion diagnostics, ensuring that biomarker data translates into actionable insights.
OHMX.bio provides:

Analyze complex data

Process raw sequencing data, perform quality control, and conduct differential analysis to pinpoint significant biomarkers.

Integrate multi-omics data

Combine genomic, epigenetic, and transcriptomic information to build a comprehensive biological picture, increasing the predictive power of the biomarker signature.

OHMX.bio_Innovative omics solutions

Partner with OHMX.bio for CDx Solutions

From biomarker discovery to clinical implementation, OHMX.bio is your trusted partner in companion diagnostics. With a unique combination of laboratory expertise and advanced bioinformatics, OHMX.bio ensures that your CDx project achieves the highest standards in sensitivity, specificity, and regulatory compliance. Contact us to explore how we can accelerate your companion diagnostic development.

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using companion diagnostics (CDx) solutions

  1.